PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib

被引：0
|
作者：
Leiping Wang
Qunling Zhang
Jian Zhang
Si Sun
Haiyi Guo
Zhen Jia
Biyun Wang
Zhimin Shao
Zhonghua Wang
Xichun Hu
机构：
[1] Fudan University,Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College
[2] Fudan University,Department of Breast Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College
来源：
BMC Cancer | / 11卷
关键词：
Trastuzumab; Capecitabine; Lapatinib; PI3K Pathway; PIK3CA Mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Targeting the PI3K pathway in the brain - pharmacokinetics and efficacy of a PI3k inhibitor optimized to cross the blood-brain barrier
    Salphati, Laurent
    Pang, Jodie
    Cheong, Jonathan
    Plise, Emile G.
    Alicke, Bruno
    Ding, Xiao
    Dotson, Jennafer
    Feng, Dingzhou
    Heffron, Tim
    Joachico, Allan
    Lee, Leslie B.
    Ndubaku, Chudi
    Nishimura, Merry
    Nonomiya, Jim
    Olivero, Alan
    Phillips, Heidi
    Sideris, Setve
    Wang, Lan
    Zhang, Xiaolin
    DRUG METABOLISM REVIEWS, 2011, 43 : 183 - 183
  • [32] Targeting the PI3K Pathway in the Brain-Efficacy of a PI3K Inhibitor Optimized to Cross the Blood-Brain Barrier
    Salphati, Laurent
    Heffron, Timothy P.
    Alicke, Bruno
    Nishimura, Merry
    Barck, Kai
    Carano, Richard A.
    Cheong, Jonathan
    Edgar, Kyle A.
    Greve, Joan
    Kharbanda, Samir
    Koeppen, Hartmut
    Lau, Shari
    Lee, Leslie B.
    Pang, Jodie
    Plise, Emile G.
    Pokorny, Jenny L.
    Reslan, Hani Bou
    Sarkaria, Jann N.
    Wallin, Jeffrey J.
    Zhang, Xiaolin
    Gould, Stephen E.
    Olivero, Alan G.
    Phillips, Heidi S.
    CLINICAL CANCER RESEARCH, 2012, 18 (22) : 6239 - 6248
  • [33] Targeting the PI3K pathway in cancer
    Workman, P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S80 - S80
  • [34] Targeting the PI3K pathway in cancer
    Mills, GB
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S4 - S4
  • [35] The PI3K Pathway in Human Disease
    Fruman, David A.
    Chiu, Honyin
    Hopkins, Benjamin D.
    Bagrodia, Shubha
    Cantley, Lewis C.
    Abraham, Robert T.
    CELL, 2017, 170 (04) : 605 - 635
  • [36] Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib
    Till, Kathleen J.
    Abdullah, Mariah
    Alnassfan, Tahera
    Janet, Gallardo Zapata
    Marks, Thomas
    Coma, Silvia
    Weaver, David T.
    Pachter, Jonathan A.
    Pettitt, Andrew R.
    Slupsky, Joseph R.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [37] PI3K pathway in prostate cancer: All resistant roads lead to PI3K
    Park, Soonbum
    Kim, Young Sik
    Kim, Davis Yeon
    So, Insuk
    Jeon, Ju-Hong
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1870 (02): : 198 - 206
  • [38] Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib
    Kathleen J. Till
    Mariah Abdullah
    Tahera Alnassfan
    Gallardo Zapata Janet
    Thomas Marks
    Silvia Coma
    David T. Weaver
    Jonathan A. Pachter
    Andrew R. Pettitt
    Joseph R. Slupsky
    Scientific Reports, 13
  • [39] ACTIVATION OF PI3K/MTOR PATHWAY IN PEDIATRIC LOW-GRADE GLIOMAS AND INFLUENCE ON CLINICAL OUTCOME
    Mueller, S.
    Romero, E.
    Onar, A.
    Sottero, T.
    Nicolaides, T.
    Phillips, J.
    Zheng, S.
    Wiencke, J. K.
    McBride, S. M.
    Cowdrey, C.
    Prados, M. D.
    Berger, M. S.
    Banerjee, A.
    Gupta, N.
    Haas-Kogan, D. A.
    NEURO-ONCOLOGY, 2010, 12 (06) : II92 - II93
  • [40] A MAP for PI3K activation on endosomes
    Alex G. Batrouni
    Jeremy M. Baskin
    Nature Cell Biology, 2020, 22 : 1292 - 1294
12345